ARGC logo

Arion Group Corp. (ARGC)

Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Arion Group Corp. (ARGC) ist im Financial Services-Sektor taetig, zuletzt notiert bei $2.50 mit einer Marktkapitalisierung von 20M. Bewertet mit 45/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.

Zuletzt analysiert: 15. März 2026
45/100 KI-Bewertung MCap 20M Vol 100

Arion Group Corp. (ARGC) Finanzdienstleistungsprofil

CEOJay Hamilton
HauptsitzCity Of Industry, US
IPO-Jahr2018

Arion Group Corp., operating in the financial services sector as a shell company, focuses on the dietary supplement industry and cannabis cultivation consulting. With a negative P/E ratio and volatile stock performance, the company faces significant financial challenges and operates in a speculative market segment.

Datenherkunft | Finanzdaten Quantitative Analyse NASDAQ Analyse: 15. März 2026

Investmentthese

Investing in Arion Group Corp. presents a highly speculative opportunity. The company's negative P/E ratio of -232.84 and a profit margin of -393.5% indicate significant financial challenges. Revenue growth, if any, is a key factor to monitor. The company's involvement in the cannabis cultivation consulting space could provide growth opportunities, but this is subject to regulatory risks and market volatility. The company's beta of -0.14 suggests a low correlation with the overall market, which could offer diversification benefits, but also reflects its unique risk profile. Investors should carefully weigh the potential for high returns against the substantial risk of capital loss.

Basierend auf FMP-Finanzdaten und quantitativer Analyse

Wichtige Highlights

  • Market capitalization of $0.02 billion indicates a micro-cap company with high growth potential but also significant risk.
  • Negative P/E ratio of -232.84 reflects the company's current lack of profitability.
  • Gross margin of 38.9% suggests some efficiency in production and distribution, but is offset by high operating expenses.
  • Profit margin of -393.5% highlights substantial losses and operational inefficiencies.
  • Beta of -0.14 indicates a negative correlation with the market, suggesting the stock may move independently of broader market trends.

Wettbewerber & Vergleichsunternehmen

Staerken

  • Involvement in the growing dietary supplement market.
  • Consulting services in the expanding cannabis cultivation sector.
  • Established presence in the United States.
  • Potential for innovation in product formulations.

Schwaechen

  • Negative profit margin and lack of profitability.
  • Limited market capitalization and financial resources.
  • Dependence on regulatory changes in the cannabis industry.
  • Competition from established players in both sectors.

Katalysatoren

  • Upcoming: Potential regulatory changes in the cannabis industry could create new opportunities for consulting services.
  • Ongoing: Increasing consumer demand for dietary supplements may drive revenue growth.
  • Ongoing: Strategic partnerships with cultivators and dispensaries could expand market reach.

Risiken

  • Potential: Changes in regulations could negatively impact the cannabis consulting business.
  • Ongoing: Intense competition in the dietary supplement market may limit market share.
  • Ongoing: Negative profit margin and lack of profitability pose a significant financial risk.
  • Potential: Limited financial disclosure increases the risk of investing in Arion Group Corp.
  • Potential: Low trading volume and liquidity can lead to price volatility.

Wachstumschancen

  • Expansion of Dietary Supplement Product Line: Arion Group Corp. can expand its product line to include innovative and specialized dietary supplements catering to specific health needs. The global dietary supplements market is projected to reach $287.7 billion by 2028, growing at a CAGR of 9.6%. By focusing on niche markets and developing unique formulations, Arion Group Corp. can capture a larger share of this growing market. Timeline: 2-3 years.
  • Strategic Partnerships in Cannabis Cultivation: Forming strategic partnerships with cannabis cultivators and dispensaries can provide Arion Group Corp. with access to a broader customer base and enhance its consulting services. The legal cannabis market is expected to reach $90.4 billion by 2026. These partnerships can also facilitate the development of customized cultivation plans and compliance strategies. Timeline: 1-2 years.
  • Geographic Expansion within the United States: Expanding operations to new states within the United States can increase Arion Group Corp.'s market reach and revenue potential. Focusing on states with favorable regulations for dietary supplements and cannabis cultivation can provide a competitive advantage. This expansion requires careful planning and resource allocation. Timeline: 3-5 years.
  • Development of Proprietary Formulations: Investing in research and development to create proprietary formulations for dietary supplements can differentiate Arion Group Corp.'s products from competitors. These formulations can target specific health benefits and cater to the growing demand for personalized nutrition. This requires significant investment in scientific research and regulatory compliance. Timeline: 2-4 years.
  • Enhancement of Online Presence and E-commerce Capabilities: Strengthening its online presence and e-commerce capabilities can enable Arion Group Corp. to reach a wider audience and increase sales of its dietary supplements. Investing in digital marketing, social media engagement, and a user-friendly online platform can enhance brand awareness and customer loyalty. This requires ongoing investment in technology and marketing. Timeline: 1 year.

Chancen

  • Expansion into new geographic markets within the United States.
  • Development of strategic partnerships with cultivators and dispensaries.
  • Introduction of new and innovative dietary supplement products.
  • Increased demand for cannabis cultivation consulting services.

Risiken

  • Changes in regulations affecting the dietary supplement and cannabis industries.
  • Increased competition from larger and more established companies.
  • Economic downturn affecting consumer spending on supplements.
  • Potential for product liability claims and recalls.

Wettbewerbsvorteile

  • Proprietary formulations in dietary supplements (if any).
  • Expertise in cannabis cultivation planning and compliance.
  • Established relationships with suppliers and distributors (if any).

Ueber ARGC

Arion Group Corp., incorporated in 2016 and based in City of Industry, California, operates within the financial services sector, specifically as a shell company. The company's primary activities revolve around the manufacturing and distribution of dietary ingredients and nutritional supplements in the United States. Additionally, Arion Group Corp. provides consulting services to third parties involved in cannabis cultivation, focusing on planning, design, and regulatory compliance. Since its inception, Arion Group Corp. has navigated the dynamic landscape of the dietary supplement and cannabis industries. The company's business model encompasses both product-based revenue from supplements and service-based revenue from consulting. The company's operations are primarily based in the United States. Arion Group Corp. faces competition from established players in both the dietary supplement and cannabis consulting markets. The company's financial performance, characterized by a negative profit margin, reflects the challenges inherent in these competitive and evolving sectors.

Was das Unternehmen tut

  • Manufactures and distributes dietary ingredients.
  • Manufactures and distributes nutritional supplements.
  • Provides consulting services for cannabis cultivation planning.
  • Provides consulting services for cannabis cultivation design.
  • Provides consulting services for cannabis cultivation compliance.

Geschaeftsmodell

  • Generates revenue through the sale of dietary ingredients and nutritional supplements.
  • Earns fees by providing consulting services to cannabis cultivators.
  • Focuses on serving the United States market.

Branchenkontext

Arion Group Corp. operates within the shell company segment of the financial services sector, focusing on the dietary supplement and cannabis consulting industries. The dietary supplement market is characterized by increasing consumer awareness of health and wellness, driving demand for various products. The cannabis consulting market is rapidly evolving due to changing regulations and increasing legalization of cannabis in various states. These industries are highly competitive, with numerous players vying for market share. Arion Group Corp.'s success depends on its ability to differentiate its products and services, navigate regulatory hurdles, and achieve profitability in these dynamic markets.

Wichtige Kunden

  • Consumers seeking dietary ingredients and nutritional supplements.
  • Third-party cannabis cultivators requiring planning services.
  • Third-party cannabis cultivators requiring design services.
  • Third-party cannabis cultivators requiring compliance services.
KI-Zuversicht: 79% Aktualisiert: 15. März 2026

Finanzdaten

Chart & Info

Arion Group Corp. (ARGC) Aktienkurs: $2.50 (+0.00, +0.00%)

Aktuelle Nachrichten

Keine aktuellen Nachrichten fuer ARGC verfuegbar.

Analystenkonsens

Konsens-Bewertung

Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer ARGC.

Kursziele

Wall-Street-Kurszielanalyse fuer ARGC.

MoonshotScore

45/100

Was bedeutet diese Bewertung?

Der MoonshotScore bewertet das Wachstumspotenzial von ARGC auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.

Klassifizierung

Branche Shell Companies

Fuehrung: Jay Hamilton

CEO

Jay Hamilton serves as the CEO of Arion Group Corp. His background includes experience in business management and strategic planning. He has been involved in various aspects of the company's operations, including product development, marketing, and sales. His expertise lies in identifying market opportunities and driving business growth. Prior to joining Arion Group Corp., Hamilton held leadership positions in other companies within the consumer products sector.

Erfolgsbilanz: Under Jay Hamilton's leadership, Arion Group Corp. has focused on expanding its product line and strengthening its market presence. Key achievements include establishing partnerships with distributors and increasing brand awareness. Strategic decisions have centered on investing in research and development to create innovative dietary supplement formulations. The company has also navigated regulatory challenges in the cannabis cultivation sector.

ARGC OTC-Marktinformationen

The OTC Other tier represents the lowest tier of the OTC market, characterized by limited disclosure requirements and higher risk. Unlike companies listed on major exchanges like the NYSE or NASDAQ, OTC Other companies often do not meet minimum financial standards and may not be required to file regular reports with the SEC. This lack of transparency increases the potential for fraud and manipulation. Investors should exercise extreme caution and conduct thorough due diligence before investing in OTC Other stocks.

  • OTC-Stufe: OTC Other
  • Offenlegungsstatus: Unknown
Liquiditaet: Liquidity for Arion Group Corp. on the OTC market is likely to be limited, potentially leading to wide bid-ask spreads and difficulty in executing large trades without significantly impacting the price. Low trading volume can exacerbate these issues, making it challenging for investors to enter or exit positions quickly. Investors should be prepared for potential price volatility and illiquidity.
OTC-Risikofaktoren:
  • Limited financial disclosure increases the risk of investing in Arion Group Corp.
  • Low trading volume and liquidity can lead to price volatility.
  • Potential for fraud and manipulation is higher on the OTC market.
  • OTC Other companies often have limited operating history and financial resources.
  • Dependence on regulatory changes in the cannabis industry adds uncertainty.
Sorgfaltspruefung-Checkliste:
  • Verify the company's registration and compliance status with regulatory agencies.
  • Review available financial statements and assess the company's financial health.
  • Research the background and experience of the company's management team.
  • Evaluate the company's business model and competitive landscape.
  • Assess the potential risks and challenges facing the company.
  • Monitor news and developments related to the company and its industry.
  • Consult with a qualified financial advisor before investing.
Legitimitaetssignale:
  • Established presence in the dietary supplement market.
  • Provision of consulting services in the cannabis cultivation sector.
  • Company incorporation in 2016.
  • Physical headquarters in City of Industry, California.
  • CEO leadership.

Arion Group Corp. Aktie: Wichtige Fragen beantwortet

What are the key factors to evaluate for ARGC?

Arion Group Corp. (ARGC) currently holds an AI score of 45/100, indicating low score. Key strength: Involvement in the growing dietary supplement market.. Primary risk to monitor: Potential: Changes in regulations could negatively impact the cannabis consulting business.. This is not financial advice.

How frequently does ARGC data refresh on this page?

ARGC prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven ARGC's recent stock price performance?

Recent price movement in Arion Group Corp. (ARGC) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Involvement in the growing dietary supplement market.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider ARGC overvalued or undervalued right now?

Determining whether Arion Group Corp. (ARGC) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying ARGC?

Before investing in Arion Group Corp. (ARGC), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Why might investors consider adding ARGC to a portfolio?

Potential reasons to consider Arion Group Corp. (ARGC) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Involvement in the growing dietary supplement market.. Additionally: Consulting services in the expanding cannabis cultivation sector.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.

Can I buy fractional shares of ARGC?

Yes, most major brokerages offer fractional shares of Arion Group Corp. (ARGC) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track ARGC's earnings and financial reports?

Arion Group Corp. (ARGC) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for ARGC earnings announcements is recommended.

Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.

Offizielle Ressourcen

Analyse aktualisiert am KI-Bewertung taeglich aktualisiert
Datenquellen & Methodik
Marktdaten bereitgestellt von Financial Modeling Prep & Yahoo Finance. KI-Analyse durch proprietaere Algorithmen von Stock Expert AI. Technische Indikatoren nach branchenueblichen Berechnungsstandards. Zuletzt aktualisiert: .

Daten dienen ausschliesslich zu Informationszwecken.

Analysehinweise
  • Limited information available on OTC-listed companies.
  • Financial data may not be fully up-to-date.
Datenquellen

Popular Stocks